4-Amino-2-(substituted methyl)-2-butenoic acids: substrates and potent inhibitors of gamma-aminobutyric acid aminotransferase.
4-Amino-2-(substituted methyl)-2-butenoic acids: substrates and potent inhibitors of gamma-aminobutyric acid aminotransferase.
复制标题
4-氨基-2-(取代甲基)-2-丁烯酸:γ-氨基丁酸转氨酶的底物和有效抑制剂。
DOI:
10.1021/jm00155a029
复制
发表时间:
1986
影响因子:
7.3
通讯作者:
Invergo,BJ
中科院分区:
文献类型:
--
作者:
Silverman,RB;Durkee,SC;Invergo,BJ
4-Amino-2-(substituted methyl)-2-butenoic acids, where X (the substituted group)= F, Cl, OH, are synthesized from Cbz-protected tert-butyl 4-aminobutanoate. Successive substitutions at the-carbon by phenylseleno and hydroxymethyl groups, followed byelimination of the selenoxide and halide substitution at the hydroxymethyl group, afford the compounds in good yields. An unexpected degree of stereoselectivity is observed in the selenoxide elimination step, which yields the desired E isomer as the sole product. These compounds complement two previously reported series of compounds (Silverman, R. B.; Levy,. A. Biochem. Biophys. Res. Commun. 1980, 95, 250-255; J. Biol. Chem. 1981, 256, 11565-11568) and are used in an approach to map a section of theactive site of y-aminobutyric acid aminotransferase (GABA-T). None of these compounds is a time-dependent inactivator of GABA-T, but all are potent competitive reversible inhibitors; the hydroxy compound has a K, value of 5 µ. That these compounds are not inactivators suggests that either elimination of X does not occur or that there is no active site nucleophile in the appropriate position for reaction following elimination. With use of the fluoro analogue, enzyme-catalyzed fluoride ion release is demonstrated, indicating that elimination does occur. Unlike the previous two series of compounds (op. cit.) in which exclusive elimination occurs when the substituent is a halogen but exclusive transamination prevails for the hydroxyl-substituted analogues, in the series described here, the fluoro analoguegives a 4: 1 ratio of elimination to transamination. This suggests that the 2, 3-double bond stabilizes the product of azallylic isomerization of the Schiff base between the fluoro compound and pyridoxal phosphate. The results described here indicate that the design of a mechanism-based inactivator for GABA-T should not be based on electrophile generation near the 2-position of enzyme-bound GABA. Furthermore, substitution of an inhibitor with a 2-hydroxymethyl group (or other hydrogen-bonding substituent) and a 2, 3-double bond may lend auspicious binding propertiesto the molecule for GABA-T.It has been shown that convulsions can occur when the level of y-aminobutyric acid (GABA) in the brain dimin-ishes below a critical amount and that direct administra-tion of GABA into the brain terminates the seizures. 1'3 However, GABA does not cross the blood-brain barrier, a protective membrane that prevents xenobiotics from entering the brain. Consequently, GABA is not an effec-tive anticonvulsant agent. Recently, efforts have been directed toward the discovery of compounds that inhibit y-aminobutyric acid aminotransferase (EC 2.6. 1.19; GABA-T), 4 5678'9 a brain enzyme responsible for the catabolism of GABA. This would result in an increase in the con-